Graft-versus-myeloma effect in two cases
- 1 March 1996
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 347 (9004) , 800-801
- https://doi.org/10.1016/s0140-6736(96)90871-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft [see comments]Blood, 1994
- Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid LeukemiaNew England Journal of Medicine, 1994
- Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell doseBlood, 1993
- T-cell depletion of HLA-identical transplants in leukemiaBlood, 1991
- AMPLIFICATION OF THE GRAFT-VERSUS-LEUKEMIA EFFECT IN MAN BY INTERLEUKIN-2Transplantation, 1991
- Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsBlood, 1990
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivityNature, 1979
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979